Search Legislation

The National Health Service (Pharmaceutical Services) Regulations 2012

 Help about what version

What Version

  • Latest available (Revised)
  • Original (As made)
 Help about opening options

Opening OptionsExpand opening options

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Action following deferrals

This section has no associated Explanatory Memorandum

24.—(1) Where a Primary Care Trust (PCT1) receives a routine or excepted application, consideration or determination of which may be deferred, if it does decide to defer consideration or determination of that application (whether before or after the application is notified, in the case of a notifiable application), it must—

(a)notify the applicant (A) of its decision and the reasons for it; and

(b)where possible, notify A of the period for which the application is being deferred (if necessary by reference to a future event rather than a period of time).

(2) If the application is—

(a)a routine application, consideration of which may be deferred under regulation 14(1)(a), 16(1)(a), 19(2)(a) or 21(1)(a), it must proceed as soon as is practicable to invite other applications under regulation 14(1)(b), 16(1)(b), 19(2)(b) or 21(1)(b), in such manner as it sees fit;

(b)a routine application, consideration of which may be deferred under regulation 14(2), 16(3), 19(3) or 21(3), it must make arrangements that enable it to consider the other applications at the same time as A’s application, as soon as is practicable;

(c)a routine application, consideration of which may be deferred under regulation 14(3), 16(4), 19(4) or 21(4), it must, once the appeal relating to the other application has reached its final outcome, notify A of that outcome and that A must within a specified period (of not less than 30 days)—

(i)update A’s application, and

(ii)notify PCT1 as to whether or not A still wishes to proceed with the application;

(d)a routine application, consideration of which may be deferred under regulation 16(2) or 21(2), it must keep under regular review the issue of whether the future circumstances that gave rise to the deferral have arisen;

(e)a routine application, consideration of which may be deferred under regulation 32, it must—

(i)send A a copy of the designation that led to the decision,

(ii)review that decision once the designation that led to the decision has been cancelled or is varied in a manner which means the application may no longer be deferred under regulation 32,

(iii)notify A of the cancellation or variation, and

(iv)require A within a specified period (of not less than 30 days)—

(aa)to update A’s application, and

(bb)to notify PCT1 as to whether or not A still wishes to proceed with the application;

(f)a routine or excepted application, consideration of which may be deferred under regulation 34, once the outcome of the cause for the deferral is known, PCT1 must notify A that A must within a specified period (of not less that 30 days)—

(i)update A’s application; and

(ii)notify PCT1 as to whether or not A still wishes to proceed with the application; and

(g)a routine application, consideration of which must be deferred under regulation 38(4), it must proceed, as soon as is practicable, with the determination of whether the relevant area is or is not to be part of a controlled locality.

(3) If A informs the Primary Care Trust within the period specified under sub-paragraph (2)(c), (e)(iv) or (f) that A does not wish to proceed with the application, or fails to respond in the required manner to the notification within the specified period, the application is to be treated as withdrawn.

Back to top

Options/Help